Company intelligence / Profile preview

ETKA Biotechnology

Atakum/Samsun, Samsun, Turkeyetka.com ↗

Ownership: Private
Development stage: Other

Overview

ETKA Biotechnology is an active Turkish biotechnology company specializing in providing advanced molecular diagnostics, next-generation sequencing, microarray analysis, metagenomics profiling, and biostatistics support to academic institutions and industry clients. The company does not have its own drug or diagnostic products in clinical development but offers high-throughput genomic services using state-of-the-art platforms such as Illumina NextSeq/MiSeq NGS systems and BioRad ddPCR[3][4].

Modalities: Next-generation sequencing (NGS)MicroarrayDroplet digital PCR (ddPCR)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Gen Era Diagnostics A.Ş. – collaboration for high-tech laboratory services in Turkey[4]

Beyond the preview

Go deeper on ETKA Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ETKA Biotechnology.

Explore the full profile